Eight of nine experts expressed feeling “extremely confident” about prescribing ZORYVE foam to patients of diverse skin and hair types, including individuals with previous hair treatments, based on ...

NDA supported by positive efficacy and safety data from the Phase 2 and pivotal Phase 3 trials of roflumilast foam If approved, roflumilast foam would be the first topical drug for seborrheic ...

Once-daily, steroid-free topical foam intentionally formulated to help manage psoriasis across difficult-to-treat areas of the body including the scalp Approval supported by pivotal Phase 3 and Phase ...